Fundraising Fox

Launchpad Therapeutics, Inc.

Cambridge, US · Founded 2022 · Delaware corporation · 2 known investors

Biotech

Founders & leadership

AM
Alexander MaywegExecutive
AK
Anna KohlmannExecutive

Board

ABAli Behbahani
Ali BehbahaniinBoard directorPartner, Co-Head of Healthcare at New Enterprise Associates (NEA)

Investors · 2

New Enterprise Associates (NEA)reported · 2 sourcesMenlo Park · $200K – $40Mvia Ali Behbahani · board
Versant VenturesreportedSan Francisco · $250K – $5M

Reported raises · per SEC filings

Form D private placements

$10M disclosed across 1 round · 2022

▶$10MraisedDec 2022 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alexander MaywegExecutive Officer, Director
  • Ali BehbahaniDirector
  • Anna KohlmannExecutive Officer
Offering amount
$30M
Amount sold
$10M
First sale
Dec 2022
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Black Diamond Therapeutics Announces Spinout of Launchpad Therapeutics, Inc., an Antibody-Focused Precision Oncology Companyglobenewswire.com · Dec 2022

Frequently asked questions

Who are Launchpad Therapeutics, Inc.'s investors?
Launchpad Therapeutics, Inc.'s investors include New Enterprise Associates (NEA), Versant Ventures.
How much funding has Launchpad Therapeutics, Inc. raised?
Launchpad Therapeutics, Inc. has disclosed $10M raised across 1 round.
Where is Launchpad Therapeutics, Inc. headquartered?
Launchpad Therapeutics, Inc. is headquartered in Cambridge, US.